Neutrogena Skin360 BIPA Violation Class Action Settlement
Case Overview
Johnson & Johnson, a consumer health company that sells skincare products under the Neutrogena brand, agreed to settle claims that it violated Illinois privacy laws by collecting biometric data through its Skin360 app without proper consent.
The plaintiffs alleged that Johnson & Johnson violated Illinois’ Biometric Information Privacy Act (BIPA) by gathering, keeping, sharing, and profiting from biometric facial geometry from the Neutrogena skin app without first providing the legally required written disclosures and obtaining written consent. BIPA governs all biometric data collected in Illinois, including facial geometry scans.
Under the settlement, class members are eligible to receive a cash payment, though the exact amount depends on the number of claims filed. Johnson & Johnson also committed to deleting any images taken during skin assessments and maintaining BIPA-compliant user notices going forward. Class members must submit a valid claim form by November 25, 2026, as the final approval hearing is set for December 17, 2026.
Who May Qualify
Illinois residents who used any version of Skin360, including Neutrogena Skin360 or NeoStrata Skin360, via a mobile or web application between December 9, 2019, and May 5, 2023.
Frequently Asked Questions
Who is eligible for this settlement?
The settlement benefits Illinois residents who performed a Skin360 skin assessment using any version of the app, including Neutrogena Skin360 or NeoStrata Skin360, via a mobile or web application between December 9, 2019, and May 5, 2023.
What did the lawsuit claim?
The lawsuit alleged that Johnson & Johnson violated Illinois’ Biometric Information Privacy Act (BIPA) by collecting, storing, and profiting from biometric facial geometry from the skin app without providing the legally required written disclosures and obtaining written consent.